Oliveira Steven Michael 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-29 11:44 am Purchase | 2024-04-22 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 791,235 8.890% | 693,032 (+705.71%) | Filing |
| 2023-08-18 10:50 am Sale | 2023-08-08 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 98,203 3.890% | -24,395 (-19.90%) | Filing |
| 2022-10-07 12:46 pm Purchase | 2022-09-14 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 122,598 8.080% | 83,297 (+211.94%) | Filing |
| 2021-04-14 5:17 pm Purchase | 2021-04-12 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 39,301 13.870% | 16,061 (+69.11%) | Filing |
| 2021-04-05 06:01 am Purchase | 2021-04-01 | 13G | Benitec Biopharma Inc. BNTC | Oliveira Steven Michael | 23,240 8.200% | 23,240 (New Position) | Filing |